India virus covid-19 patient India

Covid treatment drug: Roche’s antibody cocktail is now available in India

Reading now: 569
www.livemint.com

₹59,750 inclusive of all taxes. The maximum retail price for the multidose pack (each pack can treat two patients) is ₹119,500 inclusive of all taxes.In total they can potentially benefit 200,000 patients as each of the 100,000 packs that will be available in India offers treatment for two patients.

Cipla will distribute the product by leveraging its strong distribution strengths across the country. The drug will be available through leading hospitals and COVID treatment centers. “Roche is deeply committed to support the ongoing efforts to combat the COVID-19 pandemic, mitigate the deadly second wave and save lives.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA